1MRKX:BIT
Merck & Co.
€ 128.18
arrow_downward
-0.59%(-0.76) Siku 1
2 Okt, 17:26:00 GMT +2 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
ABC27
·
saa 7 zilizopita
Pharmaceutical company commits to $2.9B investment at Pennsylvania plant
Barron's
·
saa 9 zilizopita
Lilly, Merck, AbbVie Stocks Surge. Why Healthcare Is Rallying Today.
Kalkine Media
·
saa 10 zilizopita
What Are the Key Drivers Behind Merck (NYSE:MRK) Stock?
MarketBeat
·
saa 11 zilizopita
Merck & Co., Inc. (NYSE:MRK) Stock Jumps 3.6% - Still a Buy?
Wasifu
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue.
The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products.
The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000.
In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia